A Lithuanian manufacturer partnered with ProBaltic Consulting to finance a research laboratory for developing an innovative PET formula free of toxicological effects on human health and with a positive environmental impact. The project was funded under the EU R&D measure “Intelektas LT+” (Intelligence LT+).
The challenge
Developing a new polymer formula is a classic R&D problem: the outcome cannot be guaranteed in advance, and proving it safe and environmentally superior requires systematic laboratory experimentation. That uncertainty is exactly what qualifies a project for R&D funding — but it also means the application must demonstrate a credible research plan, not just an equipment purchase.
What we did
ProBaltic Consulting assessed the company’s needs and the eligibility of both the applicant and the research idea, then prepared the full funding application under Intelligence LT+ — framing the laboratory investment as the infrastructure of a defined research programme with clear technological uncertainty to resolve.
The result
The funding was secured and the laboratory installed. The new product developed through the project materially improved the company’s performance: exports and profitability increased significantly, lifting value added and labour productivity — and moving the company closer to its principal long-term strategic goal. A product with no toxicological impact on human health also strengthened the company’s position in markets where safety and environmental requirements keep tightening.
The takeaway
Equipment alone rarely wins R&D funding; a laboratory embedded in a genuine research plan does. This case is a textbook example of how manufacturers in Lithuania can finance product-development infrastructure through EU R&D measures.
Planning a similar project? We assess eligibility free of charge within 1–2 business days, and our fee applies only to funding you win. See the current major EU funding calls in Lithuania or contact us.